GeD,FellayJ,ThompsonAJ,SimonJS,ShiannaKV,UrbanTJ, 2009.Genetic variation in IL-28B predicts hepatitis-C treatmentinduced viral clearance,Nature 461 399 -401
ThompsonAJ,MuirAJ,SulkowskiMS,GeD,FellayJ,ShiannaKV, 2010.Interleukin-28B polymorphism improves viral kinetics and is the strongest pre-treatment predictor of sustained virologic response in hepatitis-C virus-1 patients,Gastroenterology 139 120 -9
McHutchisonJG,LawitzEJ,MuirAJ,GallerGW,McConeJ, 2009.Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis-C infection,N Engl J Med 36 580 -93
ThomasDL,ThioCL,MartinMP,QiY,GeD,O'HuiginC, 2009.Genetic variation in IL-28B and spontaneous clearance of hepatitis-C virus,Nature 461 798 -801
ButiM,EstebanR, 2015.Hepatitis-C virus genotype-3: a genotype that is not 'easy-to-treat',Expert Rev Gastroenterol Hepatol 9 375 -85
FabrisC,FalletiE,CussighA,BitettoD,FontaniniE, 2011.-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC,J Hepatol 54 716 -22
LanghansB,KupferB,BraunschweigerI,ArndtS,SchulteW,NischalkeHD, 2011.Interferon-lambda serum levels in hepatitis-C,J Hepatol 54 859 -65
AkkarathamrongsinS,ThongVD,PoovorawanK,PrapunwattanaP, 2014.IFNL3 (IL-28B) and IFNL-4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype-1, but not with genotypes-3 and 6,J Med Virol 86 1482 -90
GuptaAC,TrehanpatiN,SukritiS,HissarS,MidhaV,SoodA, 2014.Interleukin-28b CC genotype predicts early treatment response and CT/TT genotype-spredicts non-response in patients infected with HCV genotype-3,J Med Virol 86 707 -12
EslamM,LeungR,Romero-GomezM,MangiaA,IrvingWL,SheridanD, 2014.IFNL-3 polymorphisms predict response to therapy in chronic hepatitis-C genotype 2/3 infection,J Hepatol 61 235 -41
MangiaA,MottolaL,SantoroR, 2013.Interleukin-28B polymorphisms as predictor of response in hepatitis-C virus genotype-2 and 3 infected patients,World J Gastroenterol 19 8924 -8
MoghaddamA,MelumE,ReintonN,Ring-LarsenH,VerbaanH,BjøroK, 2011.-28B genetic variation and treatment response in patients with hepatitis-C virus genotype-3 infection,Hepatology 53 746 -54
MangiaA,ThompsonAJ,SantoroR,PiazzollaV,TillmannHL,PatelK, 2010.An IL-28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response,Gastroenterology 139 821 -7
BrunoS,ThompsonAJ,CritelliR,CrosignaniA,RossiS,De LisiS, 2015.Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study,Antiviral Res 113 27 -32
SuppiahV,MoldovanM,AhlenstielG,BergT,WeltmanM,AbateML, 2009.IL28B is associated with response to chronic hepatitis-C interferon-alpha and ribavirin therapy,Nature Genetics 41 1100 -4
TanakaY,NishidaN,SugiyamaM,KurosakiM,MatsuuraK,SakamotoN, 2009.Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis-C,Nature Genetics 41 1105 -9
StättermayerAF,StauberR,HoferH,RutterK,BeinhardtS,ScherzerTM, 2011.Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis-,Clin Gastroenterol Hepatol 9 344 -50
RauchA,KutalikZ,DescombesP,CaiT,Di IulioJ,MuellerT, 2010.Genetic variation in IL-28B is associated with chronic hepatitis-C and treatment failure: a genome-wide association study,Gastroenterology 138 1338 -45
GélinasJF,FabreT,WillemsP,LeungRC,GeorgeJ,WillemsB, 2013.IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test,Immunogenetics 65 397 -403
StättermayerAF,StrasslR,MaieronA,RutterK,StauberR,StrasserM, 2014.Polymorphisms of interferon-λ−4 and IL-28Beffects on treatment response to interferon/ribavirin in patients with chronic hepatitis-C. Aliment Pharmacol Ther, 39 104 -11
SusserS,HerrmannE,LangeC,HamdiN,MüllerT,BergT, 2014.Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis-C,PLoS One 9 e112592 -
JiaZ,DingY,TianS,NiuJ,JiangJ, 2012.Test of IL-28B polymorphisms in chronic hepatitis-C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a metaanalysis,PLoS One 7 e45698 -